Michael David  Staffieri net worth and biography

Michael Staffieri Biography and Net Worth

COO of DaVita
Michael D. Staffieri became our Chief Operating Officer, DaVita Kidney Care, in March 2014. From July 2011 to February 2014, he served as a Senior Vice President, Kidney Care. Mr. Staffieri initially joined us in July 2000 and served in different roles since that time, including as our Vice President of Operations and New Center Development form March 2008 to July 2011. Prior to joining us, Mr. Staffieri worked for Arthur Andersen LLP in Finance from 1999 to 2000.

What is Michael David Staffieri's net worth?

The estimated net worth of Michael David Staffieri is at least $4.75 million as of February 21st, 2024. Mr. Staffieri owns 37,687 shares of DaVita stock worth more than $4,750,823 as of April 18th. This net worth approximation does not reflect any other assets that Mr. Staffieri may own. Additionally, Mr. Staffieri receives a salary of $1,650,000.00 as COO at DaVita. Learn More about Michael David Staffieri's net worth.

How old is Michael David Staffieri?

Mr. Staffieri is currently 50 years old. There are 6 older executives and no younger executives at DaVita. The oldest executive at DaVita is Mr. Joel Ackerman, CFO & Treasurer, who is 59 years old. Learn More on Michael David Staffieri's age.

What is Michael David Staffieri's salary?

As the COO of DaVita Inc., Mr. Staffieri earns $1,650,000.00 per year. The highest earning executive at DaVita is Mr. Javier J. Rodriguez, CEO & Executive Director, who commands a salary of $2,980,000.00 per year. Learn More on Michael David Staffieri's salary.

How do I contact Michael David Staffieri?

The corporate mailing address for Mr. Staffieri and other DaVita executives is 2000 16TH STREET, DENVER CO, 80202. DaVita can also be reached via phone at (720) 631-2100 and via email at [email protected]. Learn More on Michael David Staffieri's contact information.

Has Michael David Staffieri been buying or selling shares of DaVita?

Michael David Staffieri has not been actively trading shares of DaVita within the last three months. Most recently, Michael David Staffieri sold 29,488 shares of the business's stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $119.81, for a transaction totalling $3,532,957.28. Following the completion of the sale, the chief operating officer now directly owns 37,687 shares of the company's stock, valued at $4,515,279.47. Learn More on Michael David Staffieri's trading history.

Who are DaVita's active insiders?

DaVita's insider roster includes Joel Ackerman (CFO), Pamela Arway (Director), Charles Berg (Director), Barbara Desoer (Director), Paul Diaz (Director), John Nehra (Director), Paula Price (Director), Javier Rodriguez (CEO), Michael Staffieri (COO), Kathleen Waters (Insider), and Phyllis Yale (Director). Learn More on DaVita's active insiders.

Are insiders buying or selling shares of DaVita?

In the last year, insiders at the sold shares 9 times. They sold a total of 181,836 shares worth more than $21,270,343.49. The most recent insider tranaction occured on February, 26th when CEO Javier Rodriguez sold 67,603 shares worth more than $8,525,414.33. Insiders at DaVita own 1.4% of the company. Learn More about insider trades at DaVita.

Information on this page was last updated on 2/26/2024.

Michael David Staffieri Insider Trading History at DaVita

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/21/2024Sell29,488$119.81$3,532,957.2837,687View SEC Filing Icon  
6/23/2022Buy20,000$77.70$1,554,000.0061,190View SEC Filing Icon  
11/30/2020Sell25,000$109.74$2,743,500.00View SEC Filing Icon  
8/9/2016Sell20,262$73.09$1,480,949.5852,279View SEC Filing Icon  
5/16/2016Sell4,934$75.69$373,454.4612,279View SEC Filing Icon  
5/28/2015Sell9,050$84.07$760,833.50View SEC Filing Icon  
5/18/2015Sell2,047$82.03$167,915.41View SEC Filing Icon  
1/23/2015Sell21,869$76.05$1,663,137.45View SEC Filing Icon  
5/7/2014Sell2,633$67.30$177,200.90View SEC Filing Icon  
4/2/2014Sell2,867$69.15$198,253.052,633View SEC Filing Icon  
See Full Table

Michael David Staffieri Buying and Selling Activity at DaVita

This chart shows Michael David Staffieri's buying and selling at DaVita by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

DaVita Company Overview

DaVita logo
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Read More

Today's Range

Now: $126.06
Low: $125.64
High: $128.57

50 Day Range

MA: $130.01
Low: $109.86
High: $139.24

2 Week Range

Now: $126.06
Low: $71.51
High: $141.54

Volume

370,555 shs

Average Volume

816,675 shs

Market Capitalization

$11.06 billion

P/E Ratio

17.04

Dividend Yield

N/A

Beta

1.04